pentoxifylline has been researched along with Rheumatoid Arthritis in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Under the conditions of our trial, the therapeutic benefits provided by pentoxifylline were too small to warrant use of this drug in severe refractory rheumatoid arthritis." | 9.08 | An open study of the anti-TNF alpha agent pentoxifylline in the treatment of rheumatoid arthritis. ( Beaujon, G; Bussière, JL; Dubost, JJ; Oualid, T; Ristori, JM; Sauvezie, B; Soubrier, M, 1997) |
| "12 patients with active rheumatoid arthritis were treated with 1200 mg pentoxifylline and 100 mg thalidomide a day during 12 weeks." | 7.69 | An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. ( Breedveld, FC; Dijkmans, BA; Huizinga, TW; van de Pouw Kraan, TC; van der Velde, EA; Verweij, CL, 1996) |
| "Pentoxifylline was also reported to possess therapeutic properties in 50% of severe refractory RA in an open study." | 5.30 | [Remission induction after pentoxifylline treatment in a patient with rheumatoid arthritis]. ( Ichikawa, Y; Ishii, O; Kase, C; Moriuchi, E; Ohya, S; Yamada, H; Yamasaki, K, 1997) |
| "Under the conditions of our trial, the therapeutic benefits provided by pentoxifylline were too small to warrant use of this drug in severe refractory rheumatoid arthritis." | 5.08 | An open study of the anti-TNF alpha agent pentoxifylline in the treatment of rheumatoid arthritis. ( Beaujon, G; Bussière, JL; Dubost, JJ; Oualid, T; Ristori, JM; Sauvezie, B; Soubrier, M, 1997) |
| "12 patients with active rheumatoid arthritis were treated with 1200 mg pentoxifylline and 100 mg thalidomide a day during 12 weeks." | 3.69 | An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. ( Breedveld, FC; Dijkmans, BA; Huizinga, TW; van de Pouw Kraan, TC; van der Velde, EA; Verweij, CL, 1996) |
| "Concomitantly to AIA, mice presented alveolar bone loss, and recruitment of osteoclasts and neutrophils to periodontal tissues." | 1.39 | Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice. ( Bessoni, RL; Costa, VV; Queiroz-Junior, CM; Silva, TA; Souza, DG; Teixeira, MM, 2013) |
| "Pentoxifylline was also reported to possess therapeutic properties in 50% of severe refractory RA in an open study." | 1.30 | [Remission induction after pentoxifylline treatment in a patient with rheumatoid arthritis]. ( Ichikawa, Y; Ishii, O; Kase, C; Moriuchi, E; Ohya, S; Yamada, H; Yamasaki, K, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Queiroz-Junior, CM | 1 |
| Bessoni, RL | 1 |
| Costa, VV | 1 |
| Souza, DG | 1 |
| Teixeira, MM | 1 |
| Silva, TA | 1 |
| Anaya, JM | 1 |
| Espinoza, LR | 1 |
| Maksymowych, WP | 1 |
| Avina-Zubieta, A | 1 |
| Luong, MH | 1 |
| Russell, AS | 1 |
| Huizinga, TW | 1 |
| Dijkmans, BA | 1 |
| van der Velde, EA | 1 |
| van de Pouw Kraan, TC | 1 |
| Verweij, CL | 1 |
| Breedveld, FC | 1 |
| Dubost, JJ | 1 |
| Soubrier, M | 1 |
| Ristori, JM | 1 |
| Beaujon, G | 1 |
| Oualid, T | 1 |
| Bussière, JL | 1 |
| Sauvezie, B | 1 |
| Ishii, O | 1 |
| Yamada, H | 1 |
| Ohya, S | 1 |
| Moriuchi, E | 1 |
| Kase, C | 1 |
| Ichikawa, Y | 1 |
| Yamasaki, K | 1 |
| Kiely, PD | 1 |
| Johnson, D | 1 |
| Bourke, BE | 1 |
| Wendling, D | 1 |
| Toussirot, E | 1 |
| Raza, A | 1 |
| Smolian, H | 1 |
| Aurer, A | 1 |
| Sittinger, M | 1 |
| Zacher, J | 1 |
| Bernimoulin, JP | 1 |
| Burmester, GR | 1 |
| Kolkenbrock, H | 1 |
2 reviews available for pentoxifylline and Rheumatoid Arthritis
| Article | Year |
|---|---|
Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Hum | 1995 |
Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes.
Topics: Arthritis, Rheumatoid; Crohn Disease; Etanercept; Humans; Immunoglobulin G; Myelodysplastic Syndrome | 2000 |
3 trials available for pentoxifylline and Rheumatoid Arthritis
| Article | Year |
|---|---|
An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Sedimentation; Enzyme-Linked Immunosorbent Assay; Female; | 1995 |
An open study of the anti-TNF alpha agent pentoxifylline in the treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Outcome Assessment, | 1997 |
An open study of oxpentifylline in early rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Pentoxifylline; Phosphodieste | 1998 |
5 other studies available for pentoxifylline and Rheumatoid Arthritis
| Article | Year |
|---|---|
Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice.
Topics: Alveolar Bone Loss; Animals; Antigens; Arthritis, Experimental; Arthritis, Rheumatoid; C-Reactive Pr | 2013 |
An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chemotherapy, Adjuvant; Hematologic Tests; Humans; Immu | 1996 |
[Remission induction after pentoxifylline treatment in a patient with rheumatoid arthritis].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Hu | 1997 |
TNF-alpha-targeted therapy in rheumatoid arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Arthritis, Rheumatoid; Dru | 1999 |
Secretion of gelatinases and activation of gelatinase A (MMP-2) by human rheumatoid synovial fibroblasts.
Topics: Arthritis, Rheumatoid; Concanavalin A; Cyclic CMP; Cytochalasin D; Enzyme Activation; Enzyme Inhibit | 2001 |